8-K: Village Farms Reports Strong Q2 2026 with Record Cannabis Sales

Sentiment:

Quarterly Results


Village Farms International announced robust second quarter 2026 results, driven by record cannabis revenues of $53.5 million, a 5% increase year-over-year, and significant growth in international exports.

Capital raiseOn June 5, 2026, the Company entered into securities purchase agreements for a registered direct offering of 7,500,000 common shares to two U.S. institutional investors, yielding gross proceeds of approximately $15 million before fees and expenses.

Summary

  • Village Farms International reported strong financial results for the second quarter ended June 30, 2026.
  • Consolidated net sales reached $64 million, a 7% increase year-over-year.
  • Net income was $7.1 million, or $0.06 per share.
  • Operating cash flow was $8.9 million.
  • The cannabis segment achieved record revenues of $53.5 million, up 5% year-over-year, with a gross margin of 51%.
  • International export sales hit a record $20.9 million, up 74% year-over-year.
  • The company ended the quarter with $73 million in cash.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong sequential and year-over-year growth in key cannabis segments, record revenues, and improved profitability metrics.

Positives

  • Record cannabis revenues of $53.5 million for Q2 2026, a 5% increase year-over-year.
  • Consolidated net sales increased 7% year-over-year to $64 million.
  • Net income of $7.1 million ($0.06 per share) and positive operating cash flow of $8.9 million.
  • Record international export sales of $20.9 million, up 74% year-over-year and 43% sequentially.
  • Cannabis segment Adjusted EBITDA from continuing operations reached a record $15.3 million, representing 29% of sales.
  • Achieved record harvest yields in Delta facilities with improved cost of production.
  • Canadian brands achieved top 10 market share in all major categories.
  • Company ended Q2 with $73 million in cash.

Negatives

  • Cash flow from operations for the six months ended June 30, 2026, was negative at $(2.8) million, compared to positive $22.1 million in the prior year period.
  • Total net sales for the six months ended June 30, 2026, increased 15% to $114.2 million, but the cost of sales also increased by 2% to $63.3 million.
  • Selling, general and administrative expenses increased by 29% for the six months ended June 30, 2026, to $34.8 million.

Risks

  • Limited operating history in the cannabis and cannabinoids industry.
  • Uncertainty regarding the legality and regulatory status of cannabis and cannabinoid products in the United States.
  • Risks related to the implementation and enforcement of new legislation affecting the CBD business in the United States.
  • Potential difficulties in achieving and maintaining profitability.
  • Variability of product pricing.
  • Risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses.
  • Risks related to the start-up of international production at Netherlands operations.
  • Changes in governmental regulations and obtaining/maintaining required licenses.

Future Outlook

The company expects to ramp Netherlands operations to full production capacity by the end of Q1 next year and the Delta 2 expansion to reach its full production run rate by mid-2027. Village Farms anticipates continued profitable growth and expects to grow its cash balance from positive operating cash flow through the remainder of the year.

Management Comments

  • "Our second quarter results continue to demonstrate the strength of our expanding global cannabis platform, driven by record cannabis revenues of $53.5 million as we continued to grow in target markets and product categories around the world."
  • "We delivered our fifth consecutive quarter of positive net income and EPS since we privatized our legacy produce business last year..."
  • "We're having a record year of production in our Delta, British Columbia facilities even without including the first harvest we completed in our Delta 2 greenhouse expansion, and record yields combined with greater operating efficiencies have resulted in a lower cost of production."
  • "We continue to expect that we'll enter multiple new European jurisdictions later this year."
  • "We're entering the second half of the year in a position of strength, and we're positioned for continued profitable growth regardless of our entry point and timing into the U.S. market with a global cannabis enterprise that is now approaching 50% of revenues from growing international markets."
  • "We continue to evaluate additional organic and acquisitive growth investments around the world, but remain prudent and patient with respect to valuation with a focus on profitability and long-term value creation for our shareholders."

Industry Context

StockSavvy.ai notes that Village Farms' performance aligns with the growing global demand for cannabis products, particularly in international markets like Europe. The company's focus on EU-GMP certification and expanding production capacity positions it to capitalize on these trends, while also navigating the evolving regulatory landscape.

Stakeholder Impact

  • Shareholders: Positive impact from increased revenues, profitability, and cash position, with a focus on long-term value creation.
  • Employees: Continued growth may lead to job creation and opportunities within the expanding global operations.
  • Customers: Access to a wider range of cannabis products and potentially improved product quality due to yield improvements.
  • Suppliers: Increased demand for cultivation inputs and services as production scales up.

Next Steps

  • Netherlands operations expected to ramp to full production capacity by the end of Q1 next year.
  • Delta 2 expansion in Canada is on track to reach its full 40 tonne production run rate by mid-2027.
  • Expect to enter multiple new European jurisdictions later this year.
  • Continue to evaluate additional organic and acquisitive growth investments globally.

Key Dates

DateDescription
June 30, 2026End of the second quarter for which financial results are reported.
August 10, 2026Date of the press release announcing Q2 2026 financial results and the date of the Form 8-K filing.

Recommendation

hold

The company is demonstrating strong operational execution and growth in its core cannabis business, with record revenues and improved margins. However, the negative cash flow from operations for the six-month period and ongoing capital expenditure for expansions warrant a cautious 'hold' rating until sustained positive cash flow and profitability are clearly established across all segments.

Keywords

Cannabis, Financial Results, Revenue Growth, International Exports, Adjusted EBITDA, Harvest Yields, Market Share, Cash Flow

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.